Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA Topoisomerase II Beta (TOP2B)
- Target
- TOP2B
- Molecular classification
- Enzyme, DNA Topoisomerase, Type II Topoisomerase
01
Overview
DNA Topoisomerase II Beta (TOP2B) is a type II topoisomerase enzyme essential for managing DNA topology during transcription, replication, chromosome condensation, and chromatid separation. It introduces transient double-stranded breaks in DNA to relieve torsional stress and resolve catenanes. TOP2B is a target for anticancer agents, but mutations can lead to drug resistance and other disease states.
- Other names
- Topoisomerase (DNA) II BetaDNA topoisomerase 2-betaTop2b
02
Mechanism of action
Drugs targeting TOP2B, such as mitoxantrone, induce double-strand breaks in DNA by interfering with the enzyme's ability to religate the DNA after strand passage.
03
Biological functions
DNA topology managementTranscription regulationReplicationChromosome condensationChromatid separationRelieving torsional stress
04
Disease associations
CancerImmunodeficiencyNeurological disorders (e.g., autism)Drug resistanceAtaxia-telangiectasia (possible)
05
Safety considerations
Drug resistanceInduction of secondary malignanciesCardiotoxicity (for some TOP2B inhibitors)
06
Interacting drugs
Mitoxantrone
2 more in the full profile.
Beyond the preview
Go deeper on DNA Topoisomerase II Beta (TOP2B).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DNA Topoisomerase II Beta (TOP2B).